Swedish researchers discover a blood test that can detect Parkinson's disease up to 20 years before symptoms appear, offering ...
From opening new therapeutic mechanisms to repairing neuronal damage, investigational molecules from Ventyx Therapeutics, AC ...
Scientists in Sweden and Norway have uncovered a promising way to spot Parkinson’s disease years—possibly decades—before its most damaging symptoms appear. By detecting subtle biological signals in ...
A team led by researchers at Chalmers University of Technology, Sweden, has succeeded in identifying biomarkers for Parkinson ...
An early symptom of Parkinson’s is sleep dysfunction, according to the Journal of Clinical Sleep Medicine. Instead of ...
Investing.com -- Serina Therapeutics Inc (NYSE:SER) stock surged 30.2% in after-hours trading Wednesday following FDA ...
Advanced Parkinson's disease patients in Calgary have had access since 2024 to a treatment called Vyalev, which an Edmonton ...
Researchers have succeeded in identifying biomarkers of the debilitating disease in its earliest stages.
Shares of Serina Therapeutics surged after an investigational new drug application for a Parkinson's disease treatment was approved by the Food and Drug Administration. The stock rose 35% to $3.67 in ...
More than 1.1 million Americans live with the degenerative brain condition, which can trigger debilitating tremors and effect memory ...
News-Medical.Net on MSN
AI-designed NLRP3 inhibitor receives FDA clearance for Parkinson disease trials
Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial ...
Phase 1b clinical site start-up and regulatory activities in Australia underway to support the global registrational program -HUNTSVILLE, AL, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results